Inist to jointly develop oral ‘bazedoxifene/cholecalciferol’ combination drug

Published: 2017-09-12 16:26:00
Updated: 2017-09-12 13:47:41

Inist Bio Pharmaceutical(CEO Kook-Hyun Kim) will conduct an open innovation service of its product based on its know-hows as a CMO(contract manufacturing organization).

The company will open a briefing to suggest joint development of a bazedoxifene/cholecalciferol combination drug being develope...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.